Parathyroid hormone and trabectedin have differing effects on macrophages and stress fracture repair

• Published in: Bone (New York, N.Y.) Vol. 179; p. 116983
• Main Authors: Zweifler, Laura E, Sinder, Benjamin P, Stephan, Chris, Koh, Amy J, Do, Justin, Ulrich, Emily, Grewal, Jobanpreet, Woo, Cecilia, Batoon, Lena, Kozloff, Kenneth, Roca, Hernan, Mishina, Yuji, McCauley, Laurie K
• Format: Journal Article
• Language: English
• Published: United States 01.02.2024
• Subjects: Animals; Bony Callus - pathology; Fracture Healing; Fractures, Stress - drug therapy; Fractures, Stress - pathology; Humans; Infant; Macrophages; Male; Mice; Mice, Inbred C57BL; Parathyroid Hormone - pharmacology; Parathyroid Hormone - therapeutic use; Trabectedin - pharmacology; X-Ray Microtomography - methods; Stress fracture; Parathyroid hormone (PTH); Bone healing; Trabectedin; Macrophage
• ISSN: 8756-3282; 1873-2763; 1873-2763
• DOI: 10.1016/j.bone.2023.116983

Stress fractures occur as a result of repeated mechanical stress on bone and are commonly found in the load-bearing lower extremities. Macrophages are key players in the immune system and play an important role in bone remodeling and fracture healing. However, the role of macrophages in stress fractures has not been adequately addressed. We hypothesize that macrophage infiltration into a stress fracture callus site promotes bone healing. To test this, a unilateral stress fracture induction model was employed in which the murine ulna of four-month-old, C57BL/6 J male mice was repeatedly loaded with a pre-determined force until the bone was displaced a distance below the threshold for complete fracture. Mice were treated daily with parathyroid hormone (PTH, 50 μg/kg/day) starting two days before injury and continued until 24 h before euthanasia either four or six days after injury, or treated with trabectedin (0.15 mg/kg) on the day of stress fracture and euthanized three or seven days after injury. These treatments were used due to their established effects on macrophages. While macrophages have been implicated in the anabolic effects of PTH, trabectedin, an FDA approved chemotherapeutic, compromises macrophage function and reduces bone mass. At three- and four-days post injury, callus macrophage numbers were analyzed histologically. There was a significant increase in macrophages with PTH treatment compared to vehicle in the callus site. By one week of healing, treatments differentially affected the bony callus as analyzed by microcomputed tomography. PTH enhanced callus bone volume. Conversely, callus bone volume was decreased with trabectedin treatment. Interestingly, concurrent treatment with PTH and trabectedin rescued the reduction observed in the callus with trabectedin treatment alone. This study reports on the key involvement of macrophages during stress fracture healing. Given these observed outcomes on macrophage physiology and bone healing, these findings may be important for patients actively receiving either of these FDA-approved therapeutics.